Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1964 2
1968 1
1969 1
1971 2
1972 2
1973 3
1974 3
1976 2
1977 4
1979 1
1981 2
1982 5
1983 6
1984 9
1985 13
1986 6
1987 5
1988 6
1989 9
1990 14
1991 12
1992 13
1993 9
1994 4
1995 3
1996 14
1997 26
1998 14
1999 17
2000 19
2001 21
2002 27
2003 33
2004 27
2005 39
2006 49
2007 48
2008 51
2009 36
2010 35
2011 41
2012 50
2013 61
2014 58
2015 55
2016 44
2017 44
2018 38
2019 66
2020 47
2021 46
2022 33
2023 42
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

1,133 results

Results by year

Filters applied: . Clear all
Page 1
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.
Attal M, Richardson PG, Rajkumar SV, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Macé S, Corzo KP, Campana F, Le-Guennec S, Dubin F, Anderson KC; ICARIA-MM study group. Attal M, et al. Among authors: huang js. Lancet. 2019 Dec 7;394(10214):2096-2107. doi: 10.1016/S0140-6736(19)32556-5. Epub 2019 Nov 14. Lancet. 2019. PMID: 31735560 Clinical Trial.
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
Dimopoulos MA, Jakubowiak AJ, McCarthy PL, Orlowski RZ, Attal M, Bladé J, Goldschmidt H, Weisel KC, Ramasamy K, Zweegman S, Spencer A, Huang JSY, Lu J, Sunami K, Iida S, Chng WJ, Holstein SA, Rocci A, Skacel T, Labotka R, Palumbo A, Anderson KC. Dimopoulos MA, et al. Among authors: huang jsy. Blood Cancer J. 2020 Feb 13;10(2):17. doi: 10.1038/s41408-020-0273-x. Blood Cancer J. 2020. PMID: 32054831 Free PMC article. Review.
Glomuvenous Malformation.
Huang JS, Wang D. Huang JS, et al. J Pediatr Gastroenterol Nutr. 2023 Apr 1;76(4):e81. doi: 10.1097/MPG.0000000000003691. Epub 2022 Dec 27. J Pediatr Gastroenterol Nutr. 2023. PMID: 36728817 No abstract available.
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study.
Richardson PG, Perrot A, San-Miguel J, Beksac M, Spicka I, Leleu X, Schjesvold F, Moreau P, Dimopoulos MA, Huang JS, Minarik J, Cavo M, Prince HM, Malinge L, Dubin F, van de Velde H, Anderson KC. Richardson PG, et al. Among authors: huang js. Lancet Oncol. 2022 Mar;23(3):416-427. doi: 10.1016/S1470-2045(22)00019-5. Epub 2022 Feb 10. Lancet Oncol. 2022. PMID: 35151415 Clinical Trial.
Medical Scribes: A First Step.
Huang JS. Huang JS. J Pediatr Gastroenterol Nutr. 2021 Feb 1;72(2):181. doi: 10.1097/MPG.0000000000002985. J Pediatr Gastroenterol Nutr. 2021. PMID: 33264181 No abstract available.
Dasatinib-related chylothorax.
Huang YM, Wang CH, Huang JS, Yeh KY, Lai CH, Wu TH, Chang PH, Chang PH, Chang YS, Lan YJ. Huang YM, et al. Among authors: huang js. Turk J Haematol. 2015 Mar 5;32(1):68-72. doi: 10.4274/tjh.2012.0196. Turk J Haematol. 2015. PMID: 25805678 Free PMC article.
Response to Stillwell and Merritt.
Rebbe R, Reddy J, Kuelbs CL, Huang JS, Putnam-Hornstein E. Rebbe R, et al. Among authors: huang js. J Pediatr. 2023 Oct;261:113676. doi: 10.1016/j.jpeds.2023.113676. Epub 2023 Aug 22. J Pediatr. 2023. PMID: 37611736 No abstract available.
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Sun CP, Chiu CW, Wu PY, Tsung SI, Lee IJ, Hu CW, Hsu MF, Kuo TJ, Lan YH, Chen LY, Ng HY, Chung MJ, Liao HN, Tseng SC, Lo CH, Chen YJ, Liao CC, Chang CS, Liang JJ, Draczkowski P, Puri S, Chang YC, Huang JS, Chen CC, Kau JH, Chen YH, Liu WC, Wu HC, Danny Hsu ST, Wang IH, Tao MH. Sun CP, et al. Among authors: huang js. Mol Ther. 2023 Nov 1;31(11):3322-3336. doi: 10.1016/j.ymthe.2023.09.002. Epub 2023 Sep 9. Mol Ther. 2023. PMID: 37689971 Free article.
Telemedicine Workflow Modeling in Pediatric Gastroenterology.
Miller SD, Huang JS, Gurses AP. Miller SD, et al. Among authors: huang js. J Pediatr Gastroenterol Nutr. 2022 Apr 1;74(4):433-434. doi: 10.1097/MPG.0000000000003393. Epub 2022 Feb 4. J Pediatr Gastroenterol Nutr. 2022. PMID: 35129157 No abstract available.
1,133 results